NeuroPace (NPCE) Shares Outstanding (Weighted Average) (2020 - 2026)
NeuroPace has reported Shares Outstanding (Weighted Average) over the past 7 years, most recently at $33.7 million for Q1 2026.
- For Q1 2026, Shares Outstanding (Weighted Average) rose 7.1% year-over-year to $33.7 million; the TTM value through Mar 2026 reached $33.7 million, up 7.1%, while the annual FY2025 figure was $32.7 million, 12.35% up from the prior year.
- Shares Outstanding (Weighted Average) for Q1 2026 was $33.7 million at NeuroPace, up from $32.7 million in the prior quarter.
- Over five years, Shares Outstanding (Weighted Average) peaked at $33.7 million in Q1 2026 and troughed at $24.3 million in Q1 2022.
- A 5-year average of $28.2 million and a median of $28.3 million in 2024 define the central range for Shares Outstanding (Weighted Average).
- On a YoY basis, Shares Outstanding (Weighted Average) climbed as much as 8930.26% in 2022 and fell as far as 2.6% in 2022.
- Year by year, Shares Outstanding (Weighted Average) stood at $24.6 million in 2022, then rose by 5.11% to $25.9 million in 2023, then grew by 12.67% to $29.1 million in 2024, then grew by 12.35% to $32.7 million in 2025, then increased by 3.04% to $33.7 million in 2026.
- Business Quant data shows Shares Outstanding (Weighted Average) for NPCE at $33.7 million in Q1 2026, $32.7 million in Q4 2025, and $33.1 million in Q3 2025.